MYRIAD GENETICS INC (MYGN:NASDAQ)
$4.4 0.09 (2.0882%)
Analysed MYRIAD GENETICS INC (MYGN:NASDAQ) News Sources
3 of Wall Street’s Favorite Stocks with Open Questions
15-05-2026
yahoo.com
Down 29.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Myriad (MYGN)
18-05-2026
yahoo.com
1 Unprofitable Stock to Consider Right Now and 2 We Turn Down
23-05-2026
yahoo.com
Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI)
26-05-2026
yahoo.com
MYGN Cancer Care Strategy: What's Driving 2026 Growth Plans
27-05-2026
yahoo.com
Is MYGN Stock a Buy at 0.4x Sales? What Investors Should Weigh
28-05-2026
yahoo.com
Myriad Genetics' Upcoming Prolaris + AI Test Debut May Lift Its Stock
28-05-2026
yahoo.com
Myriad Genetics Names Raj Jampa as New Chief Technology Officer
02-06-2026
yahoo.com
3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2026
02-06-2026
yahoo.com
Dr. Crystal Nelson Explains How Genetic Testing Is Transforming Mental Health Medication Treatment on YourUpdateTV
03-06-2026
yahoo.com
What is the current price of MYRIAD GENETICS INC (MYGN:NASDAQ)?
The current price of MYRIAD GENETICS INC (MYGN:NASDAQ) is $4.4.
MYRIAD GENETICS INC (MYGN:NASDAQ) absolute price change since previous trading day?
The absolute price change of MYRIAD GENETICS INC (MYGN:NASDAQ) since the previous trading day is $0.09.
MYRIAD GENETICS INC (MYGN:NASDAQ) percentage price change since previous trading day?
The percentage price change of MYRIAD GENETICS INC (MYGN:NASDAQ) since the previous trading day is 2.0882%.
What is the most recent average sentiment score for MYRIAD GENETICS INC (MYGN:NASDAQ)?
The most recent average sentiment score for MYRIAD GENETICS INC (MYGN:NASDAQ) is 60 out of 100.
What is the most recent average sentiment for MYRIAD GENETICS INC (MYGN:NASDAQ)?
The most recent sentiment for MYRIAD GENETICS INC (MYGN:NASDAQ) is .
SEC-8K** Filing Available For MYRIAD GENETICS INC (MYGN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.